Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds chemotherapy helps women with localized ovarian cancer

27.09.2004


A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail. The findings come from an analytical review of data from 13 randomized control trials (RCTs), which will be published in the November 1, 2004 issue of CANCER, a peer-reviewed journal of the American Cancer Society. A free abstract of this article will be available via the CANCER News Room upon online publication.

About one quarter of all ovarian cancers are caught while confined to the ovaries, when five-year survival is 85 percent. But the therapeutic benefit of adjuvant chemotherapy remains controversial. All physicians agree that surgery that includes staging is critical to survival. Some doctors may prefer not to offer chemotherapy for their patients, since eight in ten are adequately treated by surgery alone. They could argue that giving all stage I patients chemotherapy would lead to unnecessary adverse events with no survival benefit for the majority of patients.

Given the controversy, Laurie Elit, M.D., of the Juravinski Regional Cancer Centre in Ontario, Canada and her colleagues conducted a meta-analysis of RCT data published since 1965.



First, adequate surgical staging was a prognostic factor for cancer survival. Most studies in this review did not show adequate staging of patients. Second, patients who received any adjuvant chemotherapy had a lower risk of death (relative risk, 0.74) and recurrence (relative risk, 0.70) than those who did not receive chemotherapy. However, insufficient data and conflicting data exist regarding the optimal regimens (e.g., three versus six cycles), optimal doses, and the role of adjuvant radiotherapy.

The authors strongly recommend that women receive appropriate surgical staging: "women with optimally staged stage I ovarian cancer, a pathology review by a gynecologic pathologist, and good prognostic factors (stage Ia or stage Ib grade 1) have an excellent prognosis without adjuvant chemotherapy." They add: "There is evidence adjuvant chemotherapy improves survival and decreases recurrence rates. What remains to be defined is the population of stage I patients who would most benefit from adjuvant therapy, the optimal chemotherapy regimen, and the dose and duration of treatment."

David Greenberg | EurekAlert!
Further information:
http://www.interscience.wiley.com/cancer-newsroom
http://www.wiley.com

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>